Insmed Inc (NASDAQ:INSM)
| 37.96 Delayed Data As of 4:00pm ET |  -0.49 / -1.27%Today’s Change | 12.09 Today|||52-Week Range 45.44 | +14.03% Year-to-Date |
Latest INSM News | Press Releases
| Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Feb 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 38.45 |
| Today’s open | 37.71 |
| Day’s range | 37.81 - 39.99 |
| Volume | 72,272 |
| Average volume (3 months) | 870,287 |
| Market cap | $3.7B |
Data as of 4:00pm ET, 03/03/2021
Growth & Valuation
| Earnings growth (last year) | -0.18% |
| Earnings growth (this year) | -1.18% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +20.48% |
| P/E ratio | NM |
| Price/Sales | 19.76 |
| Price/Book | 13.32 |
Competitors
| ---- | ||
| PTCTPTC Therapeutics Inc | -0.31 | -0.54% |
| GRFSGrifols SA | -0.16 | -0.96% |
| APLSApellis Pharmaceutic... | +0.01 | +0.02% |
Data as of 4:00pm ET, 03/03/2021
Financials
| Next reporting date | May 6, 2021 |
| EPS forecast (this quarter) | -$0.89 |
| Annual revenue (last year) | $164.4M |
| Annual profit (last year) | -$294.1M |
| Net profit margin | -178.87% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
